An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Canagliflozin 300 mg; Drug: Sitagliptin 100 mg; Drug: Metformin Sponsor: Janssen Research & Development, LLC Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Invokana | Janumet | Januvia | Metformin | Mexico Health | Study